Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Parkinson's Disease

Free Subscription 02.05.2022 1 Exp Neurol 2 J Biol Chem 1 J Neural Transm (Vienna) 1 J Neurochem 3 Mov Disord 2 Neurology 1 Neuroscience 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Exp Neurol

1. PARR-BROWNLIE LC, Itoga CA, Walters JR, Underwood CF, et al
   Oscillatory waveform sharpness asymmetry changes in motor thalamus and motor cortex in a rat model of Parkinson's disease.
   Exp Neurol. 2022 Apr 21:114089. doi: 10.1016/j.expneurol.2022.114089.
   PubMed         Abstract available
   
   

   
   J Biol Chem

2. XU B, Huang S, Liu Y, Wan C, et al
   Manganese promotes alpha-synuclein amyloid aggregation through the induction of protein phase transition.
   J Biol Chem. 2022;298:101469.
   PubMed         Abstract available
   
   
3. SANGO J, Kakihana T, Takahashi M, Katsuragi Y, et al
   USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity.
   J Biol Chem. 2022;298:101448.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. RAUSCH WD, Wang F, Radad K
   From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.
   J Neural Transm (Vienna). 2022 Apr 23. pii: 10.1007/s00702-022-02488.
   PubMed         Abstract available
   
   

   
   J Neurochem

5. XUE J, Li G, Ji X, Liu ZH, et al
   Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria.
   J Neurochem. 2022;160:540-555.
   PubMed         Abstract available
   
   

   
   Mov Disord

6. TANIMURA A, Shen W, Wokosin D, Surmeier DJ, et al
   Pathway-Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease.
   Mov Disord. 2022 Apr 29. doi: 10.1002/mds.29030.
   PubMed         Abstract available
   
   
7. KARAGIANIS JL
   Re: Risk Disclosure in Prodromal Parkinson's Disease.
   Mov Disord. 2022 Apr 28. doi: 10.1002/mds.29038.
   PubMed        
   
   
8. LANGE LM, Gonzalez-Latapi P, Rajalingam R, Tijssen MAJ, et al
   Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.
   Mov Disord. 2022 Apr 28. doi: 10.1002/mds.28982.
   PubMed         Abstract available
   
   

   
   Neurology

9. LIN J, Li C, Shang H
   Teaching Video NeuroImage: Oculogyric Crises in a 12-Year-Old Girl With Rapid-Onset Dystonia Parkinsonism.
   Neurology. 2022 Apr 28. pii: WNL.0000000000200584.
   PubMed        
   
   
10. DELGADO-ALVARADO M, Gutierrez-Gonzalez A, Marques-Llano S, Riancho J, et al
    Parkinsonism Associated With Striatal Enlarged Perivascular Spaces.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200547.
    PubMed        
    
    

    
    Neuroscience

11. MORRIS G, Schorge S
    Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches.
    Neuroscience. 2022;490:309-314.
    PubMed         Abstract available
    
    

    
    Rev Neurol

12. MELENDEZ-FLORES JD, Irabien-Zuniga M, Cerda-Contreras C, de Los Reyes-Calderon I, et al
    [Parkinson's disease phenotype based on age at onset in Latin American patients: a paired-based analysis].
    Rev Neurol. 2022;74:298-302.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: